2.1000
31-July-25 11:05:47
15 minutes delayed
Stocks
-0.0600
-2.78%
Today's range
2.0750 - 2.2000
ISIN
N/A
Source
NASDAQ
C4 Therapeutics to Present at Upcoming Investor Conferences
12 May 2021 04:00:00 By Nasdaq GlobeNewswire
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
10 Apr 2021 12:05:00 By Nasdaq GlobeNewswire